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TERESA NICOLSON,† BARBARA CONRADT,‡ AND WILLIAM WICKNER*
Molecular Biology Institute and Department of Biological Chemistry, University of California, Los Angeles, California 90024, and
Department of Biochemistry, Dartmouth Medical School, 7200 Vail Building, Hanover, New Hampshire 03755-3844
Received 6 February 1996/Accepted 10 May 1996
Vacuoles project streams of vesicles and membranous tubules into the yeast bud where they fuse, founding
the daughter cell organelle. vac5-1, which encodes a truncated form of the Pho80 cyclin, inhibits normal vacuole
inheritance. An in vitro inheritance assay which measures the fusion of vacuoles serves as a model for several
steps of this process. We find that cytosol isolated from the vac5-1 mutant is unable to promote the fusion of
wild-type vacuoles in the in vitro assay. Wild-type vacuoles are irreversibly inactivated in a time- and temper-
ature-dependent manner if preincubated with vac5-1 cytosol and ATP, suggesting the presence of a soluble
inhibitory factor. When mixed with wild-type cytosol, vac5-1 cytosol inhibits the activity of wild-type cytosol.
vac5-1 cytosol treated with trypsin or papain is still able to inhibit the activity of wild-type cytosol. Partial
fractionation of vac5-1 cytosol reveals that the protein fraction (G25 void volume) can promote fusion if
wild-type small molecules are included in the fusion reaction. In contrast, the vac5-1 small-molecule fraction
retains the full ability to inhibit fusion. Thus, the vac5-1 allele of PHO80 induces the synthesis of a small
molecule that is an inhibitor of vacuole inheritance.
Organelle partitioning during cell division is critical for cell
growth and survival (for a review, see reference 19). The yeast
vacuole forms tubular or vesicular segregation structures dur-
ing early S phase which deliver maternally derived material
into the bud until late G2 phase (3, 6). In vitro assays which
reflect the steps of in vivo inheritance were developed (3, 7) to
explore the mechanisms of vacuole partition and fusion during
cell division.
Segregation structures can be viewed microscopically in
semi-intact cells or isolated vacuoles (3). Formation of these
structures requires ATP and cytosol and is time and tempera-
ture dependent. After structure formation, isolated vacuoles
fuse and enlarge up to fivefold in diameter. This increase in
size is due to vacuole-to-vacuole fusion. This fusion can also be
assayed biochemically by measuring maturation of vacuolar
proenzymes such as procarboxypeptidase Y or proalkaline
phosphatase upon mixing of vacuole components. Homotypic
fusion apparently reflects at least the last stage in vacuole
segregation, whereby newly delivered vesicular material in the
bud fuses into a single organelle. A quantitative colorimetric
assay measuring alkaline phosphatase activity (7) has enabled
more sophisticated dissection of intervacuolar fusion. This as-
say is performed by mixing vacuoles isolated from a pho8D
strain with vacuoles isolated from a pep4D strain in the pres-
ence of ATP and cytosol. Upon fusion, the Pep4 proteinase
(proteinase A) in the pho8D vacuoles can mature pro-Pho8p
(alkaline phosphatase) in the pep4D vacuoles by removing the
pro-peptide at the pro-Pho8p C terminus. Pho8p activity can
be measured by providing a substrate, p-nitrophenyl phos-
phate, which turns yellow upon hydrolysis.
This quantitative assay has facilitated study of the vacuole
fusion event. The effects of several pharmocological reagents
have provided some insight into the types of proteins involved
in fusion. Inhibition of vacuole-to-vacuole fusion by okadaic
acid and microcystin suggests that type 1 and/or 2A serine/
threonine phosphatases are involved in intervacuolar fusion
(3). These types of phosphatases appear to have a role in regu-
lation of the fungal cell cycle (1, 4). Mutations in the PP1 gene
or disruption of PP2A in Schizosaccharomyces pombe causes
mitotic defects (12, 16). The SIT4 gene encodes a PP1/PP2A-
like phosphatase which plays a role in the G1/S phase transition
in Saccharomyces cerevisiae (18). Though okadaic acid and
microcystin inhibit a wide range of phosphatases, their effects
in the in vitro inheritance assay suggest that phosphorylation/
dephosphorylation events are involved. GTP-hydrolyzing pro-
teins also appear to be important for intervacuolar fusion.
Fusion can be inhibited by either mastoparans, nonhydrolyz-
able GTP analogs, or benzalkonium chloride (7). Further ev-
idence for G protein involvement is provided by studies which
demonstrate that Ypt7p, a small Ras-like GTPase which is
localized to the vacuole, is required for fusion (8). In addition,
an electrochemical potential is also required since CCCP, a
proton ionophore, and bafilomycin, a vacuolar ATPase inhib-
itor, block vacuole-to-vacuole fusion (2).
Mutants which are defective in vacuole inheritance, such as
vac1-1 and vac2-1, are defective in the in vitro assay (3, 7). The
defect in these strains appears to be due to a change in the
vacuoles rather than in the cytosol. Recently a new mutant,
vac5-1, was characterized in vivo and the VAC5 gene was
cloned and shown to be identical to PHO80 (15). PHO80 en-
codes a cyclin which acts as a negative regulator of phosphate
metabolism (10). Although recessive, the vac5-1 allele of
PHO80 encodes a truncated form of the cyclin which appears
to be a gain-of-function mutation. This truncated form of
Pho80p is missing the carboxy-terminal third of the protein,
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which is similar to truncations seen in other cyclins such as
CLN2 and CLN3 (9, 14). Genetic analysis demonstrates that
the vac5 truncated cyclin requires its partner kinase, Pho85,
and transcription factor targets, Pho4 and Pho2, to affect vac-
uole inheritance. In order to determine its mode of action, the
vac5-1mutant was characterized by using the in vitro assay. We
now report that the cytosol of vac5-1 has a dominant negative-
like defect in the in vitro assay and that this inhibitory activity
is due to a small molecule.
MATERIALS AND METHODS
Yeast strains. Cytosol was prepared from derivatives of TN.2B (vac5-1 ura3-
52) and TN.2C (VAC5 ura3-52) crossed into K91-A (pho8::pAL134 pho13::pPH13
ura3-52), an S. cerevisiae strain previously described by Haas et al. (7). Vacuoles were
prepared from BJ3505 (pep4::HIS3) and DKY6281 (pho8::TRP1) (7, 11).
Microscopic and spectrophotometric vacuole fusion assays. Isolation of vacu-
oles and cytosol was done as previously described (3). All preparations were
made from yeast cell cultures in log phase (1 3 107 cells/ml). Cytosol was
prepared by vortexing yeast cells in the presence of glass beads and buffer [20
mM piperazine-N,N9-bis(2-ethanesulfonic acid) (PIPES)-KOH, pH 6.8, 150 mM
potassium acetate (KOAc), 0.25 M sorbitol, 5 mM magnesium acetate
(Mg(OAc)2)]. Samples were centrifuged (3,000 3 g, 10 min) to remove intact
cells, and the supernatant was then transferred to new tubes and centrifuged
(150,000 3 g, 1 h, 48C) to remove cell debris. When the cytosol isolated from
mutant strains was cloudy, additional centrifugation was used to remove lipids.
Protein was assayed by determining the A280. Vacuoles were isolated by lysing
oxalyticase-generated yeast spheroplasts in 10 mM PIPES-KOH, pH 6.8–0.2 M
sorbitol–15% Ficoll with DEAE-dextran. The lysate was then layered beneath a
Ficoll density gradient (15 to 0%) and centrifuged (150,000 3 g, 1 h, 48C).
Vacuoles which floated to the 0%/4% interphase of the gradient were collected
and used immediately.
The visual assay of vacuole fusion was done as previously described (3).
CDCFDA-stained wild-type vacuoles isolated from BJ3505 and DKY6281 (final
concentration, 0.25 mg/ml) were labeled in vitro with 50 mM CDCFDA (10 min,
308C) and mixed in equal proportions with cytosol at a final concentration of 2.0
mg/ml and an ATP-regenerating system (3) with 1 mM ATP. In all experiments,
samples had a final volume of 30 ml comprising 20 ml of vacuoles, 6 ml of ATP
reaction buffer [final concentration, 20 mM PIPES-KOH, pH 6.8, 150 mM
KOAc, 5 mM Mg(OAc)2, 0.3 M sorbitol, 40 mM creatine phosphate, 0.2 mg of
creatine kinase per ml, 1 mMATP], and 4 ml of cytosol. Incubations were at 258C
for 2 h. Labeled vacuoles were viewed with a fluorescein filter (absorption
wavelength 450 to 490 nm). The colorimetric assay described by Haas et al. (7)
was performed as previously described and used to measure the maturation of
the pro-alkaline phosphatase present in BJ3505 vacuoles.
Protease treatment of cytosol.Wild-type or vac5-1 cytosol was treated with 1.0
mg of trypsin per ml, (final concentration, 1.0 mg/ml) for 10 min at 308C and
incubated with a 53 molar excess of trypsin inhibitor for 5 min at 308C, and the
mixture was added to a complete reaction of vacuoles plus ATP and incubated
at 258C for 2 h. Other portions of cytosol were incubated with papain bound to
beads (Sigma) for 60 min at 308C. Papain protease was removed by sedimenting
the beads in a microcentrifuge. In each case, 45 mg of treated (or untreated)
wild-type or vac5-1 cytosol was added to a complete reaction with 30 mg of
wild-type cytosol (final total concentration of cytosol, 2.5 mg/ml). The total
volume was 30 ml.
Fractionation of cytosol. G25 resin was equilibrated with cytosol buffer [20
mM PIPES-KOH, pH 6.8, 150 mM KOAc, 0.25 M sorbitol, 5 mM Mg(OAc)2] in
3-ml prepacked columns (Bio-Rad). The excess buffer was removed by sedimen-
tation in a clinical centrifuge for 2 min. Cytosol (50 to 75 ml) was layered on
approximately 1 ml of packed resin and centrifuged for 2 min. Bradford assays
were performed on the void volume fraction.
Small molecules were collected by adding cytosol at equal concentrations (15
to 20 mg/ml) to Centricon-10 ultrafiltration devices (Amicon), which are de-
signed to allow molecules with masses of less than 10 kDa to partition to a lower
chamber during centrifugation. In addition, partitioning with Centricon-3 ultra-
filtration devices (with a 3-kDa cutoff) was performed, followed by fractionation
with a spin column packed with G10 resin prepared as described above.
RESULTS
The in vitro inheritance assay requires three components:
vacuoles, an ATP-regenerating system, and cytosol. Cytosols
from vac1-1 and vac2-1 strains and from various class D vac-
uolar protein-sorting mutants (which have a vacuole segrega-
tion defect in vivo) are functional in the inheritance assay (3;
unpublished observations). In contrast, the inability of vac5-1
components to fuse in vitro is due to an altered cytosolic
component.
Figures 1A and B show the microscopic assay of intervacu-
olar fusion in reactions with either wild-type or vac5-1 cytosol.
Incubation of CDCFDA-labeled wild-type vacuoles with wild-
type cytosol promotes fusion and gives rise to large vacuoles
which are bigger than the starting size. In contrast, incubation
with vac5-1 cytosol does not promote fusion and vacuoles ei-
ther remain the same size or fragment. Defective fusion was
seen with several different strain backgrounds containing the
vac5-1 mutation (data not shown). Increasing amounts of wild-
type cytosol, up to 2.0 mg/ml, yield a proportionately higher
FIG. 1. vac5-1 cytosol is defective in promoting vacuole-to-vacuole fusion.
(A) Wild-type cytosol (2 mg/ml), 1 mM ATP, and CDCFDA-labeled wild-type
vacuoles (0.25 mg/ml) were incubated at 258C for 120 min. (B) CDCFDA-labeled
wild-type vacuoles (0.25 mg/ml) were incubated at 258C for 120 min with vac5-1
cytosol (2 mg/ml) and 1 mM ATP. (C), Concentration curve of wild-type versus
vac5-1 cytosol using the pro-alkaline phosphatase maturation assay. Incubations
were performed as described for panels A and B. (The value of a complete
reaction from which cytosol was omitted was 0.106 U.)
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signal in the Pho8p maturation assay (Fig. 1C). In contrast,
vac5-1 cytosol is more active than wild-type cytosol at low
concentrations (Fig. 1C). At these lower concentrations, the
vacuoles fuse normally and increase in size (data not shown).
As increasing amounts of vac5-1 cytosol are added, the signal
which represents vacuole fusion decreases to the level obtained
in a control reaction without ATP.
The vacuole fusion obtained with 1.0-mg/ml wild-type cy-
tosol alone (Fig. 2A and B, WT alone) is decreased by the
addition of 1.5 mg/ml vac5-1 cytosol (Fig. 2A and B, WT1 A).
In contrast, additional wild-type cytosol increases the signal
(Figure 2B, WT 1 C). Previous experiments have shown that
trypsin pretreatment of wild-type cytosol inhibits the ability of
the cytosolic components to promote intervacuolar fusion (3).
This suggests that at least some of the cytosolic components
required for fusion are proteinaceous. Protease digests were
performed to determine whether the vac5-1 inhibitory factor is
proteinaceous. Pretreatment with either trypsin or papain did
not affect the ability of vac5-1 cytosol to inhibit the activity of
wild-type cytosol (Fig. 2A and B, WT 1 B). In control reac-
tions, the same protease treatment of wild-type cytosol did not
yield inhibitory activity (Fig. 2A, WT 1 C, and 2B, WT 1 D).
The signal obtained in these controls is approximately the
same as those obtained in reactions with wild-type cytosol
alone. Separate assays showed that the proteases were active.
To determine whether the inhibition is reversible, wild-type
vacuoles were preincubated with vac5-1 cytosol and then rei-
solated for a second incubation with wild-type cytosol (Fig. 3).
Exposure of wild-type vacuoles to wild-type cytosol and ATP
during the first 0 to 30 min did not affect their ability to fuse
(Fig. 3A). The control aliquots, transferred to ice at the indi-
cated times, show the amount of fusion achieved in the first
incubation. Maximal signals were obtained if wild-type cytosol
was added in the second incubation. Addition of vac5-1 cytosol
in the second incubation had the greatest inhibitory effect at
the earlier time points. In contrast to the wild-type control,
preincubation with vac5-1 cytosol plus ATP for only 15 min
irreversibly inactivated the wild-type vacuoles (Fig. 3B).
Since protease treatment did not abolish the inhibitory ac-
tivity of vac5-1 cytosol (Fig. 2B), partial fractionation was per-
formed to determine the size of the vac5-1 factor. vac5-1 cy-
tosol was separated into a protein fraction and a small-
molecule fraction by using Sephadex G25 gel filtration and an
ultrafiltration membrane with a cutoff at 10 kDa (see Materials
and Methods). The activity of the G25 void volume fraction
was variable but was always less than the activity of unfraction-
ated cytosol (data not shown). Figure 4A shows the effects of
adding back the small-molecule fraction (mass,,10 kDa) from
wild-type cytosol or vac5-1 cytosol to a complete fusion reac-
tion with the vac5-1 protein fraction. The first two bars repre-
sent signals obtained with wild-type (dots) or vac5-1 (hatched)
G25 protein fractions alone. As more wild-type small mole-
cules are added to vac5-1 proteins, the signal increases and
reaches a plateau. In contrast, as more vac5-1 small molecules
are added to vac5-1 proteins, the signal rises initially and then
decreases, similar to the pattern obtained with unfractionated
vac5-1 cytosol (Fig. 1C). The inhibition by the vac5-1 small-
molecule fraction is maximal at 4 ml, a volume which corre-
sponds to the volume of unfractionated vac5-1 cytosol required
for comparable inhibition.
Further size fractionation of vac5-1 small molecules demon-
strates that the vac5-1 factor is bigger than 0.7 kDa and smaller
than 3.0 kDa. vac5-1 cytosol was first passed through an ultra-
filtration membrane with a cutoff at 3 kDa, and the filtrate was
then passed through G10 resin to remove small ions and mol-
ecules. Figure 4B shows the results of adding either wild-type
or vac5-1 small molecules (C3/G10 fractions; masses between
3.0 and 0.7 kDa) to wild-type G25 void volume proteins. The
wild-type small-molecule fraction still stimulates the fusion
activity of the protein fraction, whereas the vac5-1 small mol-
ecule fraction inhibits activity.
DISCUSSION
The in vitro inheritance assay measures intervacuolar fusion,
a late step in the vacuole segregation process, and vac5-1
cytosol is defective in promoting this step. In vivo, many vac5-1
mutant cells exhibit single, round mother cell vacuoles without
either segregation structures or vacuolar material in the bud
(15). If stained with fluoroscein isothiocyanate, many mutant
FIG. 2. The inhibitory activity of vac5-1 cytosol is not sensitive to proteases.
(A) Treatment of vac5-1 cytosol with trypsin does not remove inhibitory activity.
Wild-type or vac5-1 cytosol was incubated with trypsin (final concentration, 1
mg/ml) for 10 min at 308C. Trypsin inhibitor was then added (5 min at 308C), and
the mixture was incubated with a complete reaction of wild-type vacuoles and
ATP and 1-mg/ml wild-type untreated cytosol for 2 h at 258C. (B) Treatment of
vac5-1 cytosol with papain does not remove inhibitory activity. Wild-type or
vac5-1 cytosol was incubated for 60 min at 308C with papain anchored to beads.
The beads were sedimented, and the supernatant was then added to a complete
reaction as described for panel A. In each experiment, 1.5 mg of protease-treated
(or untreated) cytosol per ml as well as 1 mg of untreated cytosol per ml, was
added to the incubations with vacuoles and ATP. The background of 0.394 U
from incubations with ATP but no cytosol was subtracted.
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cells display buds which contain a single small vesicle. Taken
together, these cytological observations suggest that mutant
cells either do not form vacuolar segregation structures or only
manage to partition a small amount of material to the bud.
This is consistent with our in vitro findings that isolated wild-
type vacuoles, if incubated with vac5-1 cytosol, either remain
the same size or tend to fragment (Fig. 1).
Concentration curves of vac5-1 cytosol reveal an interesting
pattern of fusion activity that is greater than wild-type activity
at low concentrations and inactive at high concentrations. This
suggests that a factor which normally promotes fusion is
present at higher levels in vac5-1 cytosol. Too much of this
factor may inhibit intervacuolar fusion in the same way that
adding too much wild-type cytosol can inhibit fusion. If one
adds a final concentration of 4 mg/ml or more of wild-type
cytosol to a complete reaction, then fusion activity starts to
decrease (6a). In addition, excess stimulatory factor may en-
FIG. 3. Rapid inactivation of vacuoles by vac5-1 cytosol. (A) A complete
reaction of wild-type cytosol, ATP, and vacuoles was performed at 258C. Aliquots
were removed, and the vacuoles were sedimented (10,000 3 g, 1 min, 48C) and
resuspended to the same concentration in isolation buffer (0.2 M sorbitol, 10 mM
PIPES-KOH, pH 6.8). These samples were divided into three aliquots, and a
second incubation was performed with the indicated cytosols plus ATP for a total
of 120 min (the third aliquot was immediately placed on ice). (B) A complete
reaction of vac5-1 cytosol, ATP, and vacuoles was prepared and treated as
described for panel A.
FIG. 4. Size of the vac5-1 factor. (A) Fractionation of vac5-1 cytosol reveals
that the cytosolic inhibitor is a small molecule. A wild-type or vac5-1 small-
molecule fraction obtained by ultrafiltration with a Centricon-10 filter (,10-kDa
cutoff) was added to a vac5-1 G25 void volume fraction containing proteins and
molecules of .3 kDa (1 mg/ml) and assayed in the presence of ATP and
vacuoles. The total volume of each reaction was 30 ml. The first two bars compare
fusion activity of wild-type (dots) and vac5-1 (wide hatch) G25-purified proteins
alone. (B) The cytosol from wild-type and vac5-1 cells was fractionated by
passage through a Centricon-3 filter (,3 kDa cutoff) and applied to G10 resin
spin columns (0.7-kDa cutoff). The void volume from the G10 resin was added
to the G25 void volume protein fraction of wild-type cytosol (1 mg/ml). The first
bar (dots) indicates the signal obtained with wild-type G25 proteins alone.
Samples were incubated with wild-type vacuoles and ATP at 258C for 2 h. The
assay value of a complete reaction from which cytosol was omitted (for panel A,
0.190; for panel B, 0.269) was subtracted from each.
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able vac5-1 to inhibit the activity of wild-type cytosol. Alterna-
tively, vac5-1 may induce the expression of a distinct inhibitor,
although this model is not consistent with the observation that
vac5-1 cytosol has higher-than-normal activity at low concen-
trations.
Partial fractionation and protease treatment of vac5-1 cy-
tosol suggests that the vac5-1 factor is a small, protease-resis-
tant molecule with a size of between 0.7 and 3 kDa. These
results suggest that the vac5-1 factor is neither a small polypep-
tide nor a small ion. The vac5-1 inhibitory factor(s) appears to
be an overproduced component normally involved in fusion.
Since metabolic phosphatase (e.g., Pho5) expression increases
in vac5-1 strains, it seemed possible that an increase in phos-
phate might have been the cause of inhibition of vacuolar
membrane fusion. However, this is very unlikely, since the
fractionation with G10 resin removes most of the Pi. Further-
more, the amount of Pi that is present in the 3.0- to 0.7-kDa,
vac5-1 small-molecule fraction as measured by a malachite
green assay is too low to account for an inhibitory effect in the
vacuole fusion assay (unpublished observations).
The requirement for small molecules other than peptides or
ions has been shown in other reconstituted systems measuring
membrane fusion. One example is palmityl-coenzyme A, which
stimulates N-ethylmaleimide-sensitive factor-dependent cis
Golgi to trans Golgi fusion (5, 17). A second example is ara-
chidonic acid, which has an annexin-dependent role in endo-
some fusion (13). The present study provides an assay for the
purification of the small molecule which is overproduced in
vac5-1 strains. This is an essential step towards evaluating its
function in the regulation of vacuole inheritance.
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